None listed
Conditions
Brief summary
The study will review SARS-CoV-2 IgG, IgA and IgM antibodies in front-line health care workers every month for six months in comparison to symptom presentation.
Interventions
Front-line Healthcare Workers Participants will have serial (monthly) SARS-CoV-2 IgG, IgA and IgM antibody serum sample analysed for six months and Coronavirus symptom data collection. Front-line health care worker participants will be requested to records symptoms in a diary each day. This will be reviewed monthly by a research staff member.Front-line health care worker participants who develop symptoms consistent with COVID-19 will be assessed at the Coronavirus clinic as per standard practice. Any nasopharyngeal swabs collected and tested will be compared to the symptoms diary and serology results. Upon completion of 6 months, no further follow up is required.
Sponsors
Eligibility
Inclusion criteria
• Participants aged 18 years or over • Participants who are front-line health care workers that may have cared for SARS-CoV-2 positive patients and/or been involved in testing suspected SARS-CoV-2 patients and/or work in a high-risk setting. High-risk setting is defined as the Emergency Department, Intensive Care, Medical wards caring for patients with COVID-19 or dialysis unit • Participants must be accessible for follow up testing • Able to read, write and understand English Participant Information and Consent Form • Signed Participant Information and Consent Form
Exclusion criteria
• Medical or psychiatric condition or occupational responsibilities that may preclude compliance with the protocol • Research study personnel as identified in this Protocol